Progyny, Inc. OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax
Progyny, Inc. (PGNY) reported OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax of -$100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax · last filed 2026-08-07
- Progyny, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2026-06-30 was -$100.00K.
- Progyny, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2026-03-31 was -$100.00K.
- Progyny, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2025-12-31 was $100.00K.
- Progyny, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for the quarter ending 2025-09-30 was $200.00K, a 50.00% decline year-over-year.
- Progyny, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2025 was $200.00K, a 96.77% decline from fiscal 2024.
- Progyny, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2024 was $6.20M, a 27.91% decline from fiscal 2023.
- Progyny, Inc. oci, debt securities, available-for-sale, unrealized holding gain (loss), before adjustment and tax for fiscal 2023 was $8.60M.
| Period end | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 3 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 6 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 6 month as first filed | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 9 month | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$100.00K 10-Q · filed 2026-08-07 | -$200.00K 10-Q · filed 2026-08-07 | -$100.00K derived: sum of 3 quarters · filed 2026-08-07 | $100.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | -$100.00K 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $200.00K derived: sum of 3 quarters · filed 2026-05-08 | $200.00K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $300.00K derived: sum of 2 quarters · filed 2026-02-27 | $300.00K derived: sum of 3 quarters · filed 2026-08-07 | $200.00K 10-K · filed 2026-02-27 | |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-07 | $200.00K derived: sum of 2 quarters · filed 2026-08-07 | $100.00K 10-Q · filed 2025-11-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-07 | -$100.00K 10-Q · filed 2026-08-07 | $100.00K 10-Q · filed 2025-08-08 | -$200.00K derived: sum of 3 quarters · filed 2026-08-07 | $200.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$100.00K 10-Q · filed 2026-05-08 | -$200.00K derived: sum of 2 quarters · filed 2026-05-08 | $200.00K derived: sum of 3 quarters · filed 2026-05-08 | $2.80M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $300.00K derived: sum of 2 quarters · filed 2026-02-27 | $2.90M derived: sum of 3 quarters · filed 2026-02-27 | $6.20M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $400.00K 10-Q · filed 2025-11-07 | $3.00M derived: sum of 2 quarters · filed 2025-11-07 | $6.30M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $2.60M 10-Q · filed 2025-08-08 | $5.90M 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | $3.30M 10-Q · filed 2025-05-09 | ||||
| 2023-12-31 | $8.60M 10-K · filed 2026-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |